Panacos Pharmaceuticals, Inc. Panacos Pharmaceuticals, Inc.

Panacos Pharmaceuticals, Inc.

PANC

Rank in Stocks #34614
Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm... Panacos Pharmaceuticals, Inc. functions as an early-stage biotechnology firm specializing in the research and development of orally administered small-molecule therapeutics. These innovative drugs are crafted to combat human immunodeficiency virus (HIV) and various other viral diseases affecting humans. The company's scientific methodology concentrates on identifying novel targets within the viral life cycle, specifically focusing on processes like virus maturation and fusion. Currently, their product portfolio includes advanced initiatives, such as second- and third-generation programs, centered on inhibiting HIV maturation. Founded in 1999, the company's main operations are situated in Watertown, Massachusetts.
Share Price
$0.0001
Last synced: 2026-11-10
Market Cap
$5.36K
Change (1 day)
0.00%
Change (1 year)
0.00%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Trade Panacos Pharmaceuticals, Inc. (PANC)

Category

Healthcare
EPS for Panacos Pharmaceuticals, Inc. (PANC)
EPS as of September 2008 TTM: $-0.67
According to Panacos Pharmaceuticals, Inc.'s latest financial reports, its current EPS (TTM) is $-0.67. At the end of 2007 the company had an EPS of $-0.70, an increase over its 2006 EPS of $-0.75.
EPS history for Panacos Pharmaceuticals, Inc. from 2000 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-0.67 -4.29%
2007 $-0.70 -6.67%
2006 $-0.75 -56.40%
2005 $-1.72 -88.15%
2004 $-14.51 429.56%
2003 $-2.74 -68.86%
2002 $-8.80 -16.19%
2001 $-10.50 40.00%
2000 $-7.50 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$-0.89 32.84%
US
$15.66 -2,437.31%
US
$-7.07 955.22%
US
$-5.29 689.55%
AU
$12.73 -2,000.33%
BE

Questions about Panacos Pharmaceuticals, Inc.'s earnings per share (EPS)

What is Panacos Pharmaceuticals, Inc.'s earnings per share (EPS)?

Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) over the last twelve months is $-0.67, as of Sep 2008.

What was Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) in 2007?

In 2007, Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) was $-0.70, compared with $-0.75 in 2006.

How has Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) changed since 2002?

From 2002 to 2007, Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) was highest in 2007 ($-0.70) and lowest in 2004 ($-14.51).

How does Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) compare with similar companies?

Panacos Pharmaceuticals, Inc.'s earnings per share (EPS) ($-0.67) is higher than that of 3 of the 5 similar companies listed above. The highest among them is Vertex Pharmaceuticals Incorporated, with $15.66.